Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond Muhsin H. YounisSara MalihWeibo Cai Editorial 25 March 2022 Pages: 1773 - 1777
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands Katarina Sjögreen GleisnerNicolas ChouinJonathan Gear Guidelines Open access 14 March 2022 Pages: 1778 - 1809
Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT Tianyu LiuYue WuFan Wang Original Article 11 January 2022 Pages: 1810 - 1821
Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA P. BackhausF. GierseM. Schäfers Original Article Open access 27 December 2021 Pages: 1822 - 1832
Comparison of deep learning-based emission-only attenuation correction methods for positron emission tomography Donghwi HwangSeung Kwan KangJae Sung Lee Original Article 09 December 2021 Pages: 1833 - 1842
A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET Song XueRui GuoKuangyu Shi Original Article Open access 24 December 2021 Pages: 1843 - 1856
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study Nežka HribernikDaniel T HuffMartina Reberšek Original Article Open access 27 December 2021 Pages: 1857 - 1869
13 N-ammonia PET-derived right ventricular longitudinal strain and myocardial flow reserve in right coronary artery disease Masateru KawakuboMichinobu NagaoShuji Sakai Original Article 13 December 2021 Pages: 1870 - 1880
Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging Yuka OtakiSerge D. Van KriekingePiotr J. Slomka Original Article 30 December 2021 Pages: 1881 - 1893
Prediction of myocardial blood flow under stress conditions by means of a computational model Simone Di GregorioChristian VergaraGianluca Pontone Original Article 05 January 2022 Pages: 1894 - 1905
Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure Shunsuke TamakiTakahisa YamadaMasatake Fukunami Original Article 08 January 2022 Pages: 1906 - 1917
Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study Yafu YinJing WuHui Wang Original Article Open access 23 December 2021 Pages: 1918 - 1929
Morphometric analysis program and quantitative positron emission tomography in presurgical localization in MRI-negative epilepsies: a simultaneous PET/MRI study Kun GuoJingjuan WangJie Lu Original Article 23 December 2021 Pages: 1930 - 1938
Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson’s disease (PD) do not overlap Silvia MorbelliSilvia ChiolaFlavio Nobili Original Article 05 January 2022 Pages: 1939 - 1950
Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer’s disease Denise VisserSander C. J. VerfaillieRik Ossenkoppele Original Article Open access 08 January 2022 Pages: 1951 - 1963
The effect of modern PET technology and techniques on the EANM paediatric dosage card John DicksonUta EberleinMichael Lassmann Original Article Open access 15 December 2021 Pages: 1964 - 1969
[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial Elizabeth J. de KosterLioe-Fee de Geus-Oeifor the EfFECTS trial study group Original Article Open access 04 January 2022 Pages: 1970 - 1984
Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy Pu ZhangMengxin XuZhibo Liu Original Article 08 November 2021 Pages: 1985 - 1996
First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients Hasan SariClemens MingelsPaul Cumming Original Article 04 January 2022 Pages: 1997 - 2009
[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma Joris L. VosCharlotte L. ZuurWouter V. Vogel Original Article Open access 27 December 2021 Pages: 2010 - 2022
Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study Rutger MahieuDominique N. V. DondersBart de Keizer Original Article 28 December 2021 Pages: 2023 - 2036
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective Francesca SpadaDavide CampanaSergio Baldari Original Article Open access 24 December 2021 Pages: 2037 - 2048
Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus Hsin-Yu FangStefan StanglMichael Quante Original Article Open access 09 December 2021 Pages: 2049 - 2063
89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man Bastiaan M. PrivéYvonne H. W. DerksSandra Heskamp Original Article 21 December 2021 Pages: 2064 - 2076
Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement Mikhail KeslerKosta KerzhnerEinat Even-Sapir Original Article 27 December 2021 Pages: 2077 - 2085
Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT Jun WenYinjie ZhuRuohua Chen Original Article 28 December 2021 Pages: 2086 - 2095
68Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer Qihang ShangBing HaoHaojun Chen Image of the Month 07 January 2022 Pages: 2096 - 2097
PET imaging of metastatic paraganglioma using novel 3-[18F]fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) radiotracer Ka Kit WongTobias ElseDavid M. Raffel Image of the Month 28 January 2022 Pages: 2098 - 2099
Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 Eric GuedjAndrea VarroneSilvia Morbelli Correction Open access 07 March 2022 Pages: 2100 - 2101
Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma Simone KrebsChristian GrommesJoseph R. Osborne Correction 10 March 2022 Pages: 2102 - 2102
Correction to: Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers Gilles N. StormezandJanine DoorduinRudi A. J. O. Dierckx Correction 11 March 2022 Pages: 2103 - 2103
Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas R. LaudicellaN. Quartuccioon behalf of the Young Italian Association of Nuclear Medicine (AIMN) group Correction 18 March 2022 Pages: 2104 - 2104